EBS Equity Snapshot

IDIA Weekly Equity Report

Idorsia Ltd

Interactive chart JSON snapshot
Latest Close 4.54 CHF 12 Jun 2026
1W Return 5.5% latest completed week
4W Return 2.0% short-term follow-through
12W Return 44.0% quarterly tape
Trend Breadth 82.7% 43 of 52 weeks active
Volume Ratio 0.8x vs 13-week average
Company Brief

What the company does

Idorsia Ltd, a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for unmet medical needs in Switzerland, the United States, Japan, Europe, China, and Canada. The company has a clinical development pipeline for various therapeutic areas, such as CNS, cardiovascular, immunological disorders, and orphan diseases. It offers QUVIVIQ (daridorexant) for the treatment of insomnia. The company's product pipeline includes Lucerastat, a glucosylceramide synthase inhibitor, which is in phase 3 clinical trial to treat fabry disease; Daridorexant, a dual orexin receptor antagonist, which is in phase 2 clinical trial for the treatment of …

Snapshot

What the weekly tape is saying

IDIA closed the latest completed week at 4.54 CHF. The 4-week return is 2.0% and the 12-week return is 44.0%. Trend Signal is active, Market Dynamics is 0.73. Setup signature: Leadership continuation with a 74/100 composite read.

Trend Signal Active
Market Dynamics No fresh buy
Price vs Trend 19.4%
Volume 0.8x
Setup Cockpit

A compressed read of the whole setup

The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.

Composite setup radar

Scoreboard

Trend 63 Persistence of active Trend Signal over the last year and current streak.
Momentum 94 Blend of 4-week and 12-week follow-through.
Dynamics 99 Latest Market Dynamics and whether pressure has improved over four weeks.
Relative Strength 100 Relative leadership and short-term RS change.
Volume 34 Participation compared with the 13-week volume baseline.
Risk Control 57 Drawdown and recent weekly volatility pressure.

16-week signal tape

27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun
Weekly return bar Trend Signal dot Positive Market Dynamics dot
Price Action

Price, Trend Line, and Fair Value

Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.

52-week price path

Price Trend Line Fair Value

Price map

Trend Line
3.80 CHF
Vs Trend Line
19.4%
Fair Value
2.63 CHF
Vs Fair Value
72.4%
52W High
4.87 CHF
52W Low
1.80 CHF
Drawdown
-6.9%
Range Position
89.1%
Momentum

Returns and trend persistence

Return windows separate the latest week from short-term and medium-term follow-through.

Return windows

1W 5.5%
4W 2.0%
12W 44.0%
26W 9.0%
52W 123.4%

Trend read

Active Streak
5 weeks
52W Active Weeks
43
52W Active Breadth
82.7%
Sector Scope
CH Healthcare
Sector Rank
4 of 41
Sector Percentile
92.5%
Peer Context

Sector and industry pulse

Peer breadth helps separate a stock-specific move from a broader group rotation.

Market Dynamics

Pressure, Relative Strength, and expectation

Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.

Dynamics path

Market Dynamics Relative Strength

Signal state

Market Dynamics
0.73
4W MD Change
444.1%
Relative Strength
21.08
4W RS Change
-28.3%
Expectation
Positive
Probability
56.84%
Volume

Participation and confirmation

Volume tells us whether the latest weekly move is being confirmed by unusual participation.

52-week volume profile

Volume map

Latest Volume
6.8M
13W Average
8.4M
52W Average
8.2M
Vs 13W
0.8x
Vs 52W
0.8x
Risk Anatomy

Volatility, downside weeks, and return shape

A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.

26-week return distribution

Risk map

13W Volatility
6.9%
52W Volatility
10.2%
Upside Weeks
30
Downside Weeks
22
Downside Breadth
42.3%
Avg Gain / Loss
8.8% / -7.0%
Context

Classification, opportunities, risks, and watch points

Top-level read across company classification, constructive evidence, caution points, and the next things that matter.

Classification

Exchange
EBS
Country
CH
Sector
Healthcare
Industry
Biotechnology
Currency
CHF
Market Cap
1.1B

Opportunity signals

  • Trend Signal is active with a 5-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.
  • Market Dynamics is positive on the latest completed week.
  • Latest weekly return ranks in the strongest part of its sector group.

Risk signals

  • No major top-level risk cluster is currently dominant.

Watch next

  • Trend Line remains the key weekly regime level.
  • Market Dynamics is the pressure gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Weekly Tape

Recent completed weeks

The latest weekly rows behind the report snapshot.

Week Close Return Trend Fair Value MD RS Volume Signal
12 Jun 2026 4.54 CHF 5.5% 3.80 CHF 2.63 CHF 0.73 21.08 6.8M On
5 Jun 2026 4.30 CHF -3.8% 3.75 CHF 2.66 CHF 0.76 18.84 6.6M On
29 May 2026 4.47 CHF 8.1% 3.72 CHF 2.68 CHF 0.66 23.46 9.7M On
22 May 2026 4.13 CHF -7.1% 3.68 CHF 2.70 CHF 0.37 16.20 9.0M On
15 May 2026 4.45 CHF 14.3% 3.66 CHF 2.73 CHF 0.13 29.40 10.7M On
8 May 2026 3.89 CHF 5.6% 3.64 CHF 2.75 CHF -0.23 16.20 7.6M Off
1 May 2026 3.68 CHF -2.0% 3.64 CHF 2.78 CHF -0.56 11.35 11.0M Off
24 Apr 2026 3.76 CHF 1.2% 3.67 CHF 2.81 CHF -0.80 14.69 5.2M Off
17 Apr 2026 3.71 CHF 5.4% 3.66 CHF 2.84 CHF -1.07 12.82 6.9M Off
10 Apr 2026 3.52 CHF 0.3% 3.67 CHF 2.88 CHF -1.22 10.57 4.9M Off
3 Apr 2026 3.52 CHF 14.7% 3.68 CHF 2.92 CHF -1.17 13.58 6.9M Off
27 Mar 2026 3.06 CHF -2.7% 3.66 CHF 2.96 CHF -1.05 3.85 6.5M Off
20 Mar 2026 3.15 CHF -7.4% 3.65 CHF 3.00 CHF -0.69 10.36 17.8M Off
13 Mar 2026 3.40 CHF -3.7% 3.63 CHF 3.05 CHF -0.58 15.99 11.6M Off